Heroism in Microbiology and Medical Duty
Starting from the 18th century, medical deontology—the study of professional medical duty—began to take shape within microbiology. The establishment of this discipline is inextricably linked to the unprecedented self-sacrifice of researchers. Scientists willingly undertook massive risks, conducting experiments on themselves and intentionally self-inoculating.
The primary goal of these heroic acts was to definitively establish facts regarding microorganism pathogenicity, prove routes of infection transmission, and test the safety of developing vaccines. History has preserved the names of many prominent scientific figures:
- G.N. Minkh and O.O. Motsutkovsky — heroically studied epidemic typhus on themselves.
- V.P. Smirnov — conducted research on plague.
- M.N. Chumakov — worked with the poliovirus.
- M.S. Baloyan — studied the hepatitis A virus.
Immense contributions to science were also made by I.V. Savchenko and N.F. Gamaleya. These feats laid a solid ethical foundation for modern infectious disease medicine.
How Viruses Were Discovered
The late 19th century marked a revolutionary breakthrough: scientists encountered pathogens of a fundamentally new nature. A key date in biological history was 1892, when the prominent Russian botanist D.I. Ivanovsky made his epochal discovery.
While studying tobacco mosaic disease, the researcher discovered unique infectious agents. Unlike known bacteria at the time, these new microorganisms passed effortlessly through the tiny pores of bacterial filters, leading them to be termed "filterable" agents. Shortly thereafter, the Latin term virus, meaning "poison," was introduced to designate them.
Following the discovery of this plant pathogen, viruses affecting humans, animals, and even bacteria were identified. By the first half of the 20th century, the accumulated body of knowledge led to the formation of an entirely new, independent scientific discipline — virology.
Emerging Infections and the Evolution of the Microbial World
Over the past thirty to forty years, the global epidemiological landscape has undergone significant changes. Scientists are constantly identifying new pathogens. This is driven by two main factors: the rapid advancement of laboratory detection and identification methods, and the natural evolution of the microbial world (mutations and genetic shifts).
As a result, the concept of emerging infections has arisen—a group of highly dangerous and unpredictable diseases. In recent decades alone, about thirty new or significantly altered microorganism variants have been discovered:
- Viruses: HIV, causative agents of severe hemorrhagic fevers (Ebola, Marburg, and Lassa), and coronaviruses (the culprits behind severe acute respiratory syndromes).
- Bacteria: causative agents of Legionnaires' disease and Lyme disease.
Concurrently, a concerning shift in the properties of long-known microbes is occurring. Through genetic transformations, they can acquire human pathogenicity, as happened with the monkeypox virus or the bacterium Helicobacter pylori (which causes peptic ulcer disease). Additionally, a large-scale epidemic spread of "old" infections, such as chlamydia, tuberculosis, and parenteral hepatitides, is observed.
Global Triumphs and Future Outlook
Despite formidable evolutionary processes in the microbial world, medicine has achieved impressive results in combating infections. The primary triumph of global vaccination programs was the complete eradication of smallpox worldwide. Currently, global public health faces the ambitious goal of final polio eradication.
Nevertheless, expert forecasts remain realistic: the natural variability of microorganisms never stops. Humanity will inevitably continue to face the emergence of entirely new infectious agents and dangerous modifications of already known pathogens in the future.